AZN - Ionis-AstraZeneca amyloid cardiomyopathy candidate gets FDA fast track designation
2024-02-08 08:35:27 ET
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Pioneering Precision Medicine
- Ionis angioedema drug shows positive results in Phase 3 trial
- FDA approves AstraZeneca, Ionis drug for ATTRv-PN
- Seeking Alpha’s Quant Rating on Ionis Pharmaceuticals
- Historical earnings data for Ionis Pharmaceuticals